135 related articles for article (PubMed ID: 3327792)
1. Purging of bone marrow with a cocktail of monoclonal antibodies (VIB-pool) for autologous transplantation.
Zintl F; Reiners B; Thränhardt H; Hermann J; Fuchs D; Prager J
Haematol Blood Transfus; 1987; 31():89-91. PubMed ID: 3327792
[No Abstract] [Full Text] [Related]
2. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W
Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791
[No Abstract] [Full Text] [Related]
3. Preclinical studies of a panel of 12 monoclonal antibodies in view of bone marrow purging in acute lymphoblastic leukemia.
Racadot E; Herve P; Lamy B; Peters A
Leuk Res; 1987; 11(11):987-94. PubMed ID: 2961950
[TBL] [Abstract][Full Text] [Related]
4. In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia.
Ritz J; Sallan SE; Bast RC; Lipton JM; Nathan DG; Schlossman SF
Haematol Blood Transfus; 1983; 28():117-23. PubMed ID: 6345287
[No Abstract] [Full Text] [Related]
5. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555
[No Abstract] [Full Text] [Related]
6. Bone marrow purging using monoclonal antibodies.
Ramsay NK; Kersey JH
J Clin Immunol; 1988 Mar; 8(2):81-8. PubMed ID: 3286676
[No Abstract] [Full Text] [Related]
7. Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells.
Sugita K; Majdic O; Stockinger H; Holter W; Köller U; Peschel C; Knapp W
Int J Cancer; 1986 Mar; 37(3):351-7. PubMed ID: 3456339
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
[TBL] [Abstract][Full Text] [Related]
9. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
Uckun FM; Stong RC; Youle RJ; Vallera DA
J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
[No Abstract] [Full Text] [Related]
11. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibody and purging].
Ueda R; Morishima Y
Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
[No Abstract] [Full Text] [Related]
13. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody applications in bone marrow transplantation.
Reading CL; Takaue Y
Biochim Biophys Acta; 1986 Oct; 865(2):141-70. PubMed ID: 3533154
[No Abstract] [Full Text] [Related]
15. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
16. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies and immunotoxins in bone marrow transplantation: purging marrow of ALL or GVHD cells with preservation of stem cells.
Kersey JH; Vallera D; Ramsay N; Filipovich A; Youle R; Neville D; Stong R; LeBien T
Haematol Blood Transfus; 1985; 29():34-8. PubMed ID: 3896970
[No Abstract] [Full Text] [Related]
18. Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.
Freedman AS; Takvorian T; Nadler LM; Anderson KC; Sallan SE; Ritz J
Cancer Treat Res; 1988; 38():265-83. PubMed ID: 2908599
[No Abstract] [Full Text] [Related]
19. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
[TBL] [Abstract][Full Text] [Related]
20. Immunological bone marrow purging procedure in Burkitt's lymphoma. Evaluation by a liquid cell culture assay.
Favrot MC; Philip I; Maritaz O; Garçon N; Philip T
Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):455-62. PubMed ID: 3912923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
